메뉴 건너뛰기
Gut
Volumn 55, Issue 4, 2006, Pages 590-591
Life threatening intra-abdominal sepsis in patients on anti-TNF-α therapy [15]
Author keywords

[No Author keywords available]
Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; ETANERCEPT; GENTAMICIN; INFLIXIMAB; METRONIDAZOLE; TUMOR NECROSIS FACTOR ALPHA;
EID: 33645126747     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.085449     Document Type: Letter
Times cited : (19)
References (6)
  • 1
    • 0042027086 scopus 로고    scopus 로고
    • Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy
    • Kroesen S, Widmer AF, Tyndall A, et al. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology 2003;42:617-21.
    • (2003) Rheumatology , vol.42 , pp. 617-621
    • Kroesen, S.1    Widmer, A.F.2    Tyndall, A.3
  • 2
    • 0036822552 scopus 로고    scopus 로고
    • Life-threatening histoplasmosis complicating immunotherapy with tumour necrosis factor alpha antagonists infliximab and etanercept
    • Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumour necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002;46:2565-70.
    • (2002) Arthritis Rheum , vol.46 , pp. 2565-2570
    • Lee, J.H.1    Slifman, N.R.2    Gershon, S.K.3
  • 3
    • 0037331223 scopus 로고    scopus 로고
    • Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents
    • Slifman NR, Gershon SK, Lee J-H, et al. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 2003;48:319-24.
    • (2003) Arthritis Rheum , vol.48 , pp. 319-324
    • Slifman, N.R.1    Gershon, S.K.2    Lee, J.-H.3
  • 4
    • 0035846326 scopus 로고    scopus 로고
    • Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
    • Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
    • (2001) N Engl J Med , vol.345 , pp. 1098-1104
    • Keane, J.1    Gershon, S.2    Wise, R.P.3
  • 5
    • 0041653315 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report
    • Gomez-Reino JJ, Carmona L, Valverde VR, et al. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-7.
    • (2003) Arthritis Rheum , vol.48 , pp. 2122-2127
    • Gomez-Reino, J.J.1    Carmona, L.2    Valverde, V.R.3
  • 6
    • 33645116240 scopus 로고    scopus 로고
    • Update of BSR guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis
    • Ledingham J, Deighton CM. Update of BSR guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology 2003;44:157-63.
    • (2003) Rheumatology , vol.44 , pp. 157-163
    • Ledingham, J.1    Deighton, C.M.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.